Albuterol primarily treats bronchospasm associated with reversible obstructive airway diseases. This means it quickly opens narrowed airways, relieving symptoms like wheezing and shortness of breath.
Doctors prescribe albuterol for acute asthma attacks. It provides rapid relief, allowing patients to breathe easier within minutes. This quick-acting bronchodilator is a cornerstone of asthma management.
Chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis, also benefits from albuterol. It helps manage symptoms, improving airflow and reducing breathlessness. Regular use, as directed by a physician, is often part of a COPD treatment plan.
Exercise-induced bronchospasm (EIB) responds well to albuterol. Taking it before physical activity prevents or lessens exercise-triggered airway narrowing.
Albuterol inhalation is common, offering direct delivery to the lungs. This method ensures targeted action with fewer systemic side effects. Inhaled albuterol is readily available in metered-dose inhalers (MDIs) and nebulizers.
